Contrast media volume reduction with the DyeVert TM system to prevent acute kidney injury in stable patients undergoing coronary procedures
Catheterization and Cardiovascular Interventions · 2023
DOI: 10.1002/ccd.30809 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2023. Written by Luca Paolucci and 7 co-authors. Institution: Interventional Cardiology Unit, Mediterranea Cardiocentro, Naples, Italy. Major MEDLINE topics: Acute Kidney Injury, Coronary Artery Disease, Percutaneous Coronary Intervention. Cited 3 times so far (Crossref); 29 references.
Abstract (original language)
Background
Contrast associated acute kidney injury (CA‐AKI) can lead to an increased risk of adverse events. Contrast media (CM) volume reduction has been advocated as a pivotal strategy to prevent CA‐AKI in stable patients undergoing percutaneous coronary procedures.
Aims
To compare the effectiveness of CM volume reduction with the DyeVert TM system versus conventional strategy in reducing the risk of CA‐AKI.
Methods
We prospectively collected data from 136 patients with stable coronary artery disease at high risk of CA‐AKI treated with left ventricular end diastolic pressure (LVEDP)‐ guided hydration and undergoing interventions with the use of the DyeVert TM (Osprey Medical Inc.) system. Patients previously enrolled in the LVEDP‐guided hydration arm of the “Renal Insufficiency Following Contrast MEDIA Administration triaL III” (REMEDIAL III) were considered as controls. Propensity score was used to perform 1:1 matching to adjust for major confounders. The primary outcome was the occurrence of CA‐AKI, as defined by an absolute increase of creatinine values ≥0.3 mg/dL at 48 h.
Results
Patients in the DyeVert group were treated with a significant lower CM volume (median: 47.5 vs. 84.0 mL, p < 0.001). The trend in creatinine increase was lower ( p = 0.004) and the Δ of creatinine (0−48 h) showed a higher drop (−0.18 vs. −0.10 mg/dL, p = 0.036) in the DyeVert group. The risk of CA‐AKI was significantly lower in DyeVert group compared to control group (5.1% vs. 16.8%; odds ratio 0.27, 95% confidence interval [0.12−0.61]).
Conclusions
CM volume reduction with the DyeVert TM system seems to be superior to conventional strategies in reducing the occurrence of CA‐AKI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Interventional Cardiology Unit, Mediterranea Cardiocentro, Naples, Italy.
- Department of Advanced Biomedical Science, Division of Cardiology, "Federico II", University of Naples, Naples, Italy.
- Interventional Cardiology Unit, Istituto di Ricerca a Carattere Scientifico Multimedica MultiMedica, Sesto San Giovanni, Milan, Italy.
ORCID profiles: Luca Paolucci, Andrea Bezzeccheri, Amelia Focaccio
Cite
APA
Paolucci, L., De Micco, F., Bezzeccheri, A., Scarpelli, M., Esposito, G., Airoldi, F., Focaccio, A., & Briguori, C. (2023). Contrast media volume reduction with the DyeVert TM system to prevent acute kidney injury in stable patients undergoing coronary procedures. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30809
Vancouver
Paolucci L, De Micco F, Bezzeccheri A, Scarpelli M, Esposito G, Airoldi F, et al. Contrast media volume reduction with the DyeVert TM system to prevent acute kidney injury in stable patients undergoing coronary procedures. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30809
BibTeX
@article{Paolucci2023,
author = {Paolucci, Luca and De Micco, Francesca and Bezzeccheri, Andrea and Scarpelli, Mario and Esposito, Giovanni and Airoldi, Flavio and Focaccio, Amelia and Briguori, Carlo},
title = {Contrast media volume reduction with the DyeVert TM system to prevent acute kidney injury in stable patients undergoing coronary procedures},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
doi = {10.1002/ccd.30809}
}
EUVIMED